AN2 Therapeutics (ANTX) Payables (2021 - 2026)
AN2 Therapeutics' Payables came in at $1.97 million for Q2 2026, down 6.9% from $2.11 million a year earlier and down 24.8% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Payables (2021 - 2026) Analysis & Trends
At the end of FY2025, AN2 Therapeutics' Payables was $3.02 million, down 8.9% from FY2024.
- Payables carries a four-year compound annual growth rate of 29.8% (FY2021 to FY2025).
- Going back by year, Payables was $3.32 million in FY2024 (+24.0%), $2.68 million in FY2023 (+26.1%), $2.12 million in FY2022 (+99.6%) and $1.06 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Payables since Q3 2024.
- Year-over-year, Payables has declined for three consecutive quarters, with an average decline of 0.4% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in Q3 2023 (growth of 238.7%), and the weakest in Q3 2024 (a decline of 64.9%).
- Business Quant data shows ANTX's Payables at $2.62 million (Q1 2026), $3.02 million (Q4 2025) and $2.23 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | AN2 Therapeutics | 164.30 Mn | -121.79 Mn | - | 1.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.66 Mn |
| Jun 30, 2026 | 1.97 Mn |
| Mar 31, 2026 | 2.62 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 3.32 Mn |
| Sep 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.89 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 2.68 Mn |
| Sep 30, 2023 | 4.88 Mn |
| Jun 30, 2023 | 3.13 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 2.12 Mn |
| Sep 30, 2022 | 1.44 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 1.06 Mn |
API Access
AN2 Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();